The Venture Codex Logo

The Venture Codex

Overview

Goal-oriented program supporting Turkish AI initiatives and investments.

Founded

2023

Deals · 12mo

2

Links

Stage focus

Seed

Geographic focus

Türkiye

Sector focus

Investment portfolio

  • Flowla

    Participated · Seed · Jan 2026

    Flowla is a London-based startup that turns the traditional digital sales room into a unified, branded workspace that spans the entire customer journey from proposal to onboarding. Its no-code platform lets revenue teams build predefined buyer journeys with templates, AI-generated content, and automated communication rules that trigger follow-ups based on real-time buyer behaviour. For example, when a prospect views pricing, Flowla can detect their role, draft a tailored email, alert the sales rep, and queue the message for review. Founded by CEO Erdem Gelal and CTO Oguz Gelal, the company targets the persistent manual gaps that slow complex B2B deals and cause misalignment between Sales and Customer Success. By automating stakeholder coordination and follow-ups, Flowla aims to create more predictable, repeatable revenue execution. The firm has raised a $2.5 million seed round and plans to invest the proceeds in expanding its automation engine, enhancing AI-driven content capabilities, and building a dedicated U.S. go-to-market team.

  • PeriVision

    Participated · Seed · Sep 2025

    PeriVision’s core product, the VisionOne platform, fuses standard VR goggles with advanced artificial-intelligence algorithms to perform visual field examinations that are faster and more comfortable than traditional hospital equipment. Aimed at the world’s 100 million glaucoma patients, the system has already obtained certifications in the EU, the US and the UK, and its first product has been commercially launched. The company plans to broaden VisionOne with new tests for retinal disorders, add AI-driven analytics tools and build deeper clinical-integration solutions. Over the past three years, PeriVision has augmented its development with multiple non-dilutive supports, including EIT Health Wild Card, two Innosuisse project grants, FIT credit, and placements in Switzerland’s TOP100 Startups and Venture Leaders Medtech 2023. The startup is also taking part in Innosuisse Scale-up Coaching and the Biopôle Vanguard Accelerator. With the fresh capital, PeriVision intends to accelerate market expansion across Europe, the United States and the United Kingdom through 2025.

  • ERG Controls

    Participated · Seed · Jan 2024

    ERG Controls builds YIKA, a patent-backed, AI-supported product that tracks hand-hygiene activities via wearable badges and sensors. The system monitors hospital staff and is also positioned for food production facilities, restaurants, and pharmaceutical manufacturing. The company says it aims to eliminate around 50% of health-threatening risks tied to hand hygiene. ERG Controls was founded in 2020 by Batuhan Ergör and Mehmet Ergör and graduated from the Acıbadem Incubation Program and MigrosUP in 2021. Prior to the raise the team numbered 14 people; with the investment they plan to grow the team and strengthen their global footprint. Legal support for the round was provided by Aylin Sahin, Ph.D. and the Igniters Tech Law team.

Insights

Team